Acetic Acid

Acetic Acid

SCHEMBL329771

CC(=O)O.CC(=O)O.N=CCSC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 19/20 0.48
DNMT1 P26358 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12347301 0.74 KIF11 (0.53) KIF11DNMT1
SCHEMBL28658067 0.74 KIF11 (0.54) KIF11DNMT1
SCHEMBL1706141 0.74 KIF11 (0.50) KIF11DNMT1
SCHEMBL20545942 0.72 PAM (0.46) KIF11DNMT1
SCHEMBL17447160 0.71 KIF11 (0.58) KIF11
SCHEMBL25234575 0.71 KIF11 (0.41) KIF11
SCHEMBL17211092 0.71 KIF11 (0.69) KIF11DNMT1
SCHEMBL18764783 0.70 KIF11 (0.43) KIF11
SCHEMBL18764782 0.70 KIF11 (0.43) KIF11
SCHEMBL1648406 0.70 KIF11 (0.50) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1292709-B1 CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED DELIVERY OF PHARMACEUTICALLY ACTIVE COMPOUNDS EIDGENOESS TECH HOCHSCHULE (CH) 2012-01-18 EP disclosed
US-7291673-B2 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds EIDGENOSSICHE TECHNISCHE HOCHSCHULE ZURICH (CH) 2007-11-06 US disclosed
EP-1292709-A4 CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED DELIVERY OF PHARMACEUTICALLY ACTIVE COMPOUNDS EIDGENOESS TECH HOCHSCHULE (CH) 2004-09-22 EP disclosed
US-20030220245-A1 Conjugate addition reactions for the controlled delivery of pharmaceutical active compounds EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) 2003-11-27 US disclosed
EP-1292709-A1 CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED DELIVERY OF PHARMACEUTICALLY ACTIVE COMPOUNDS Eidgenössische Technische Hochschule Zürich (CH) 2003-03-19 EP disclosed
WO-2001092584-A1 CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED DELIVERY OF PHARMACEUTICALLY ACTIVE COMPOUNDS EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) 2001-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220245-A1 Conjugate addition reactions for the controlled delivery of pharmaceutical active compounds PAICS, C9, LIPA KIF11 2222/4885DNMT1 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.